CoChat

Heritability Enrichment Implicates Microglia in Parkinson's Disease Pathogenesis

Open access
Andersen, Maren Stolp, Bandres‐Ciga, Sara, Reynolds, Regina H., Hardy, John, Ryten, Mina, Krohn, Lynne, Gan‐Or, Ziv, Holtman, Inge R., Pihlstrøm, Lasse, the International Parkinson's Disease Genomics Consortium · 2021 · Annals of Neurology
Cited by 60

The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.

Abstract

Objective: Understanding how different parts of the immune system contribute to pathogenesis in Parkinson's disease is a burning challenge with important therapeutic implications. We studied enrichment of common variant heritability for Parkinson's disease stratified by immune and brain cell types. Methods: We used summary statistics from the most recent meta‐analysis of genomewide association studies in Parkinson's disease and partitioned heritability using linkage disequilibrium score regression, stratified for specific cell types, as defined by open chromatin regions. We also validated enrichment results using a polygenic risk score approach and intersected disease‐associated variants with epigenetic data and expression quantitative loci to nominate and explore a putative microglial locus. Results: We found significant enrichment of Parkinson's disease risk heritability in open chromatin regions of microglia and monocytes. Genomic annotations overlapped substantially between these 2 cell types, and only the enrichment signal for microglia remained significant in a joint model. We present evidence suggesting P2RY12 , a key microglial gene and target for the antithrombotic agent clopidogrel, as the likely driver of a significant Parkinson's disease association signal on chromosome 3. Interpretation: Our results provide further support for the importance of immune mechanisms in Parkinson's disease pathogenesis, highlight microglial dysregulation as a contributing etiological factor, and nominate a targetable microglial gene candidate as a pathogenic player. Immune processes can be modulated by therapy, with potentially important clinical implications for future treatment in Parkinson's disease. ANN NEUROL 2021;89:942–951

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/ana.26032

Cites

26 of 26 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 26 references

Cited by

See all 60

Metadata

Authors
Andersen, M. S., Bandres‐Ciga, S., Reynolds, R. H., Hardy, J., Ryten, M., Krohn, L., Gan‐Or, Z., Holtman, I. R., Pihlstrøm, L., & the International Parkinson's Disease Genomics Consortium
Venue
Annals of Neurology
Publisher
Wiley
Published
2021-03-04
Volume
89
Issue
5
Pages
942-951
ISSN
  • 0364-5134 (ISSN-L)
  • 1531-8249
OpenAlex
W3109706750
Cited by
60
References
26
FWCI
5.56
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Heritability Enrichment Implicates Microglia in Parkinson's Disease Pathogenesis. https://app.cochat.ai/papers/10.1002/ana.26032
The paper
Andersen, M. S., Bandres‐Ciga, S., Reynolds, R. H., Hardy, J., Ryten, M., Krohn, L., Gan‐Or, Z., Holtman, I. R., Pihlstrøm, L., & the International Parkinson's Disease Genomics Consortium. (2021). Heritability Enrichment Implicates Microglia in Parkinson's Disease Pathogenesis. Annals of Neurology. https://doi.org/10.1002/ana.26032

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.